India to Philippines: Bortezomib Export Trade Route
India has recorded 31 verified shipments of Bortezomib exported to Philippines, representing a combined trade value of $508.9K USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $16.4K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 24% of total export value with 3 shipments worth $122.1K USD. On the buying side, VE PHARMA INC is the largest importer in Philippines with $147.3K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, VEXXA LIFESCIENCES PVT. LTD. , SUN PHARMACEUTICAL INDUSTRIES LIMITED — together control 60% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Bortezomib corridor is one of India's established pharmaceutical export routes, with 31 shipments documented worth a combined $508.9K USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 24% of all export value, reflecting the consolidated nature of India's bortezomib manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $16.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with bortezomib's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 27.4%, placing it at rank #9 among India's top bortezomib export destinations globally.
On the import side, key buyers of Indian bortezomib in Philippines include VE PHARMA INC, SUN PHARMA PHILIPPINES INC., Ve Pharma Inc. and 7 others. VE PHARMA INC is the single largest importer with 10 shipments valued at $147.3K USD.
Route Characteristics
- Average transit19 days
- Peak seasonQ3
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#9
- Annual growth+27.4%
- Demand growth+24.8%
- Regulatory ease79/100
Top 10 Indian Bortezomib Exporters to Philippines
Showing top 10 of 11 Indian suppliers exporting Bortezomib to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $40.7K per shipment | 3 | $122.1K | 24.0% |
| 2 | VEXXA LIFESCIENCES PVT. LTD. Avg $11.9K per shipment | 8 | $94.9K | 18.6% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $44.3K per shipment | 2 | $88.7K | 17.4% |
| 4 | VEXXA LIFESCIENCES PVT. LTD. Avg $12.0K per shipment | 6 | $71.7K | 14.1% |
| 5 | VEXXA LIFESCIENCES PRIVATE LIMITED Avg $48.6K per shipment | 1 | $48.6K | 9.6% |
| 6 | VEXXA LIFESCIENCES PVT LTD Avg $10.3K per shipment | 4 | $41.1K | 8.1% |
| 7 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED Avg $18.4K per shipment | 1 | $18.4K | 3.6% |
| 8 | ADMAC LIFESCIENCES Avg $4.4K per shipment | 3 | $13.2K | 2.6% |
| 9 | GETWELL PHARMACEUTICALS Avg $8.3K per shipment | 1 | $8.3K | 1.6% |
| 10 | MALLESHWAR SPECIALITIES Avg $1.7K per shipment | 1 | $1.7K | 0.3% |
This table shows the top 10 of 11 Indian companies exporting bortezomib to Philippines, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, VEXXA LIFESCIENCES PVT. LTD. , SUN PHARMACEUTICAL INDUSTRIES LIMITED , VEXXA LIFESCIENCES PVT. LTD., VEXXA LIFESCIENCES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT LTD, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, ADMAC LIFESCIENCES, GETWELL PHARMACEUTICALS, MALLESHWAR SPECIALITIES. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 3 shipments worth $122.1K USD, giving it a 24% market share. The top 3 suppliers together account for 60% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to Philippines Bortezomib export route.
Top 10 Bortezomib Importers in Philippines
Showing top 10 of 10 known buyers in Philippines receiving Bortezomib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian bortezomib in Philippines include VE PHARMA INC, SUN PHARMA PHILIPPINES INC., Ve Pharma Inc. , SUN PHARMA PHILIPPINES INC. , AMINCORP, among 10 total buyers. The largest importer is VE PHARMA INC, accounting for $147.3K USD across 10 shipments — representing 29% of all bortezomib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VE PHARMA INC | 10 | $147.3K | 28.9% |
| 2 | SUN PHARMA PHILIPPINES INC. | 3 | $122.1K | 24.0% |
| 3 | Ve Pharma Inc. | 8 | $94.9K | 18.6% |
| 4 | SUN PHARMA PHILIPPINES INC. | 2 | $88.7K | 17.4% |
| 5 | AMINCORP | 1 | $18.4K | 3.6% |
| 6 | VE PHARMA INC. | 1 | $14.1K | 2.8% |
| 7 | PHARMASTAR INTL TRADING CORP | 3 | $13.2K | 2.6% |
| 8 | AMBICA INTERNATIONAL CORPORATION | 1 | $8.3K | 1.6% |
| 9 | RENATO C LOZADA | 1 | $1.7K | 0.3% |
| 10 | EDJOP VICTOR VILLALON PHILIPPINES | 1 | $202 | 0.0% |
Top 10 Bortezomib Formulations Imported by Philippines
Showing top 10 of 20 product formulations shipped on the India to Philippines Bortezomib route, ranked by trade value
Philippines imports a wide range of bortezomib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — BORTESUM INJ 3.5MG 1S VL PH (BORTEZOMIB — accounts for $88.7K USD across 2 shipments. There are 20 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BORTESUM INJ 3.5MG 1S VL PH (BORTEZOMIB | 2 | $88.7K | 17.4% |
| 2 | BORTESUM INJ 3.5MG 1S (BORTEZOMIB FOR INJECTION 3.5MG/VAIL) (ACT. QTY. 1045 BOX X 01 X01S)NOS | 1 | $71.7K | 14.1% |
| 3 | BORVEX 3.5MG BORTEZOMIB FOR INJ 3.5 MGB.NO.BRLJ23B04-A MANUFACTURING DT OCT-2023 EXPDT SEP-2025 | 1 | $48.6K | 9.6% |
| 4 | Borvex 3.5 (Bortezomib for inj 3.5 mg) | 4 | $43.3K | 8.5% |
| 5 | Borvex 3.5mg Bortezomib for inj 3.5 mgBCH NO-BRLH23B03-A MANUFACTURING DT-AUG-2023EXP DT-JUL-2025 | 4 | $41.1K | 8.1% |
| 6 | BORVEX 3.5 (BORTEZOMIB FOR INJECTION 3.5 | 2 | $28.8K | 5.7% |
| 7 | BORTESUN INJ 3.5 MG 1'S VL PH, (LYoPHILIZED FDRM) Bortezomib for injection 3.5 mg / viall, PACK : 01*01, Batch : HAF289 | 1 | $25.2K | 5.0% |
| 8 | BORTESUN INJ 3.5 MG 1'S VL PH, (LYoPHILIZED FORM) Bortezomib for injection 3.5 mg / viall, PACK : 01*01, Batch : HAF289 | 1 | $25.2K | 4.9% |
| 9 | Borvex 3.5mg (Bortezomib for inj 3.5 mg)BATCH NO-BRLC25B01-A MFG DT-MAR-2025 EXP DT-FEB-2027 | 1 | $23.8K | 4.7% |
| 10 | Borvex 3.5mg (Bortezomib for inj 3.5 mg) | 2 | $22.7K | 4.5% |
Showing top 10 of 20 Bortezomib formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 76%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 11 shipments. Transit time averages 19 days by sea.
Market Dynamics
India's bortezomib exports to Philippines are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, VEXXA LIFESCIENCES PVT. LTD. , SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 60% of total trade value on this route. The average shipment value of $16.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as bortesum inj 3.5mg 1s (bortezomib for injection 3.5mg/vail) (act. qty. 1045 box x 01 x01s)nos and borvex 3.5mg bortezomib for inj 3.5 mgb.no.brlj23b04-a manufacturing dt oct-2023 expdt sep-2025, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, VE PHARMA INC is the largest importer with 10 shipments worth $147.3K USD — representing 29% of all bortezomib imports from India on this route. A total of 10 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $508.9K
- Avg. Shipment
- $16.4K
- Suppliers
- 11
- Buyers
- 10
- Transit (Sea)
- ~19 days
- Annual Growth
- +27.4%
Related Analysis
Other Bortezomib Routes
Unlock the Full India to Philippines Bortezomib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 31 shipments on this route.
Frequently Asked Questions — India to Philippines Bortezomib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Bortezomib to Philippines?
The leading Indian exporters of Bortezomib to Philippines are SUN PHARMACEUTICAL INDUSTRIES LIMITED, VEXXA LIFESCIENCES PVT. LTD. , SUN PHARMACEUTICAL INDUSTRIES LIMITED . SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 24% of total trade value on this route.
Q What is the total value of Bortezomib exports from India to Philippines?
India exports Bortezomib to Philippines worth approximately $508.9K USD across 31 recorded shipments. The average value per shipment is $16.4K USD.
Q Which ports does India use to ship Bortezomib to Philippines?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 11 shipments. Indian exporters primarily use sea freight for this route, with 76% of shipments going by sea and 23% by air.
Q How long does shipping take from India to Philippines for Bortezomib?
The average transit time for Bortezomib shipments from India to Philippines is approximately 19 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Philippines Bortezomib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.4% with demand growth tracking at 24.8%. The route is ranked #9 among India's top Bortezomib export destinations globally.
Q How many suppliers are active on the India to Philippines Bortezomib route?
There are currently 11 active Indian suppliers exporting Bortezomib to Philippines. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 24% of total shipment value.
Q Who are the main importers of Bortezomib from India in Philippines?
The leading importers of Indian Bortezomib in Philippines include VE PHARMA INC, SUN PHARMA PHILIPPINES INC., Ve Pharma Inc. , SUN PHARMA PHILIPPINES INC. , AMINCORP. VE PHARMA INC is the largest buyer with 10 shipments worth $147.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Bortezomib.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 10 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 31 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
31 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists